- +852 4750 3485
- info@mycancerinfo.org
Cancer treatments are designed to kill cancer cells, block their growth, or help the immune system attack them. But cancer is not static. Over time, some cancer cells may survive initial treatment and develop changes that make them less sensitive to the therapy being used. When these resistant cells continue to grow, the treatment may become less effective or stop working altogether.
A simple way to think about this is to imagine treatment putting pressure on the cancer. The cells that are vulnerable may die off first, while the ones that are better able to adapt may remain. Over time, those more resistant cells can become the dominant population. This is one reason doctors continue monitoring with scans, blood work, and symptom review even after treatment begins.
There is no single reason why cancer treatment stops working. In many cases, resistance develops because the cancer changes at the genetic or molecular level.
Some common ways resistance may develop include:
Cancer cells can acquire new mutations over time. These changes may make a targeted therapy less effective or help cancer cells survive treatment pressure.
Some therapies are designed to attack a specific protein, receptor, or pathway. If that target changes, the treatment may no longer bind or work as intended.
Even when one pathway is blocked, cancer cells may find another route to keep growing. Researchers studying resistance often focus on these escape mechanisms.
The tissue, immune cells, and signals surrounding a tumor can also affect how well treatment works. The tumor microenvironment can sometimes protect cancer cells and reduce treatment effectiveness.
In some cases, a cancer may be resistant from the beginning rather than becoming resistant later. Some cancers do not respond to treatment from the start, while others develop resistance during therapy.
The effectiveness of cancer treatment varies among each patient.
If a treatment stops working, it does not necessarily mean there are no more options. Depending on the type of cancer, previous treatments, and the patient’s overall health, doctors may recommend switching to another therapy, combining treatments, repeating biomarker testing, or considering a clinical trial.
For patients and families, this stage can feel discouraging. But even when treatment is no longer working, there can still be meaningful choices ahead, including care focused on symptom relief, quality of life, or other treatment options. The next step depends on the individual situation and should be guided by the healthcare team.
Precision medicine is changing how doctors approach cancer treatment. Instead of treating all cancers of the same type exactly the same way, precision medicine uses information about the tumor’s genes, proteins, and biomarkers to guide more individualized care.
This is especially important when treatment resistance develops. If a tumor changes, precision medicine may help doctors identify new mutations, detect biomarkers linked to resistance, and decide whether a different targeted therapy, immunotherapy strategy, or treatment combination might be more appropriate. In other words, precision medicine helps turn a general treatment plan into a more personalized one.
A key tool supporting precision medicine is liquid biopsy. Liquid biopsy is a laboratory test done on blood, urine, or another body fluid to look for cancer cells or small pieces of DNA, RNA, or other molecules released by tumor cells into body fluids.
This matters because cancer can evolve during treatment. A traditional tissue biopsy remains important, but it is not always easy or practical to repeat often. Liquid biopsy may provide a less invasive way to monitor cancer-related changes over time and support decisions about treatment response, recurrence risk, or emerging resistance.
Liquid biopsy may support care in several ways:
Repeated sampling over time may help detect molecular changes that appear before they are obvious on imaging.
Tracking tumor-related DNA in the blood may help doctors see whether the cancer appears to be responding or evolving during therapy.
If new mutations or biomarkers appear, doctors may be able to adjust treatment more precisely.
By combining biomarker testing with clinical monitoring, doctors can make decisions that are more tailored to the biology of the individual cancer.
It is important to note that liquid biopsy is not a replacement for every tissue biopsy or for clinical judgment. Its usefulness depends on the cancer type, stage, and treatment setting. But as research advances, it is becoming an increasingly valuable tool in modern cancer care.
Drug resistance is one of the biggest challenges in oncology, but it is also one of the most active areas of research. Scientists are working to understand why resistance develops, how to detect it earlier, and how to overcome it with smarter treatment strategies.
For patients, this means that a treatment stopping does not always mean the end of options. With tools like precision medicine, biomarker testing, and liquid biopsy, doctors can often learn more about what the cancer is doing and adapt the treatment plan accordingly. Cancer care is increasingly moving away from a one-size-fits-all model and toward a more personalized, informed, and responsive approach.
At Cancer A-Z, you can request a 15 mins free-of-charge discussion with our cancer professionals.
National Cancer Institute. Definition of drug resistance.
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-resistance
National Cancer Institute. What is drug resistance?
https://www.cancer.gov/research/leading-progress/scientific-topics/what-is-drug-resistance-infograp…
National Cancer Institute. Why do cancer treatments stop working?
https://www.cancer.gov/about-cancer/treatment/research/drug-combo-resistance
National Cancer Institute. Definition of liquid biopsy.
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/liquid-biopsy
National Cancer Institute. Biomarker Testing for Cancer Treatment.
https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
NCI Division of Cancer Treatment and Diagnosis. Precision medicine trials.
https://dctd.cancer.gov/research/research-areas/clinical-trials/precision-medicine
National Cancer Institute. Liquid Biopsy: Using Tumor DNA in Blood to Aid Cancer Care.
https://www.cancer.gov/news-events/cancer-currents-blog/2017/liquid-biopsy-detects-treats-cancer
American Cancer Society. If Cancer Treatments Stop Working.
https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/if-cancer-treatments-stop-…
Precision medicine provides patients with clearer and more personalized treatment guidelines
Learn how precision medicine can help with your cancer treatment
The effectiveness of cancer treatment varies among each patient.
